Navigating Sustainable, Profitable Growth in a Rapidly Changing World

Healthcare and Pharmaceuticals

Global Cancer Biomarkers Market Rep...

Historical and Forecast Market Trends

2018-34

www.expertmarketresearch.com

The cancer biomarkers market size is propelled by several key drivers such as the growing incidence of cancer worldwide, increasing awareness and early detection efforts, advancements in biomarker discovery technologies, and the growing focus on personalized medicine. Additionally, the expansion of targeted therapies and the integration of biomarkers in drug development and clinical trials amplify market growth.

In May 2023 , Fujitsu Limited, Kyoto University, and Chordia Therapeutics, Inc. announced the start of AI field trials aimed at identifying biomarkers for cancer drug development, using Fujitsu's AI causal discovery technology. This collaboration intends to enhance the efficiency of clinical trials and the development of new cancer treatments by analyzing genomic information from Kyoto University's platform and applying advanced AI.

The project focuses on discovering biomarkers for patient stratification in treatments targeting RNA regulatory stress, a venture that began in May 2018. This effort underlines the commitment to personalized cancer treatment, leveraging cutting-edge technology to improve patient outcomes and accelerate the discovery and development of new drugs.

Government initiatives and funding for cancer research have also played a pivotal role in supporting the development and adoption of biomarker-based tests. Furthermore, the collaboration between academic institutions, research laboratories, and companies in the biopharmaceutical sector is fostering a conducive environment for the discovery of novel biomarkers and the development of biomarker-based tests and therapies.

In September 2023 , the Breast Cancer Research Foundation (BCRF) committed USD 60.2 million to fund over 250 scientists in 14 countries for breast cancer research in 2023-2024. A significant portion of this investment is directed toward advancing the understanding of cancer biomarkers, crucial for early detection, predicting treatment responses, and developing new targeted therapies.

This focus on biomarkers is part of BCRF's broader research efforts spanning prevention, treatment, and improving quality of life for breast cancer patients. As the largest private funder of breast cancer research globally, BCRF's initiatives are pivotal in driving progress against the disease.

The cancer biomarkers market demand is witnessing substantial growth, driven by an increasing recognition of their critical role in the early detection, diagnosis, and management of cancer. Cancer biomarkers offer the potential for personalized treatment plans, enabling healthcare providers to tailor therapies based on the specific genetic makeup of both the patient and the tumor, thus improving treatment outcomes and reducing side effects.

Technological advancements in genomics and proteomics have dramatically enhanced the ability to identify and validate new biomarkers, making these tools more accessible and cost-effective for clinical use. Moreover, the growing prevalence of cancer globally, coupled with heightened awareness and screening programs, is driving the demand for biomarkers in oncology diagnostics and therapeutic monitoring.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis by Type, Cancer Type, Applications, Profiling Technologies, End Users, and Region

  • In terms of biomarker types, the market comprises protein biomarkers, genetic biomarkers, and other emerging biomarkers.
  • Cancer biomarkers are applied across various cancer types including lung cancer, breast cancer, leukemia, melanoma, colorectal cancer, prostate cancer, and others, with specific biomarkers tailored to each cancer's characteristics.
  • The cancer biomarkers market segmentation is also based on applications, which includes prognostics, diagnostics, research and development, and other emerging uses.
  • Profiling technologies utilized in cancer biomarker detection encompass omics, imaging, immunoassay, bioinformatics, and other advanced methodologies.
  • End-users of cancer biomarker products and services include pharmaceuticals and biotechnology companies, diagnostics and research laboratories, hospitals, and other healthcare entities.
  • Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, each region offering unique opportunities and challenges in cancer biomarker adoption and development.

Key Findings of the Report

  • The cancer biomarkers market analysis highlights a robust growth trajectory for the cancer biomarkers market, propelled by the rising global incidence of cancer and the increasing demand for early detection and personalized medicine. This growth is further supported by advancements in technologies for biomarker discovery and validation, which are making these tools more accessible and cost-effective for clinical application.
  • A key finding is the pivotal role of technological advancements in genomics, proteomics, and bioinformatics in driving the market. These innovations enhance the precision and efficiency of cancer biomarker detection, facilitating the development of targeted therapies and contributing to the market's expansion.
  • The report identifies a wide range of applications for cancer biomarkers, including risk assessment, early detection, diagnosis, prognosis, and monitoring of therapeutic response. This diversity in application underscores the versatility of biomarkers in improving cancer care across various stages of the disease.
  • Despite the market's growth, the report points out significant challenges related to regulatory approval processes and reimbursement policies for biomarker-based tests. These challenges can impact the market's dynamics by influencing the adoption rate of new biomarker tests and therapies.
  • Another critical insight is the importance of collaborative efforts among academic institutions, research laboratories, and pharmaceutical companies in advancing biomarker research and development. Such collaborations are crucial for overcoming technical and financial barriers, leading to the discovery of novel biomarkers and the development of innovative diagnostic and therapeutic solutions.

Key Offerings of the Report

  • The EMR report gives an overview of the global cancer biomarkers market for the periods (2017-2023) and (2024-2032).
  • The report also offers the historical (2017-2023) and forecast (2024-2032) market insights for the type, cancer type, applications, profiling technologies, end users, and regions involved in the market.
  • The report analyses the market dynamics, covering the key demand and price indicators in the market, along with an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global cancer biomarkers market are Illumina, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Qiagen N.V., Thermo Fisher Scientific Inc., Myriad Genetics, Inc., Siemens Healthcare Private Limited, PerkinElmer Inc., Bio-Techne, Hologic, Inc., Quest Diagnostics Clinical Laboratories, Inc., and Charles River Laboratories.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Cancer Type
  • Applications
  • Profiling Technology
  • End-User
  • Region
Type Covered
  • Protein Biomarkers
  • Genetic Biomarkers
  • Others
Cancer Type Covered
  • Lung Cancer        
  • Breast Cancer        
  • Leukemia         
  • Melanoma        
  • Colorectal Cancer        
  • Prostate Cancer    
  • Others
Applications Covered
  • Prognostics            
  • Diagnostics            
  • Research and Development        
  • Others 
Profiling Technology Covered
  • Omics            
  • Imaging            
  • Immunoassay            
  • Bioinformatics            
  • Others  
End-Use Covered
  • Pharmaceuticals and Biotechnology Companies
  • Diagnostics and Research Laboratories
  • Hospitals                
  • Others     
Region Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Illumina, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.
  • Myriad Genetics, Inc.
  • Siemens Healthcare Private Limited
  • PerkinElmer Inc.
  • Bio-Techne
  • Hologic, Inc.
  • Quest Diagnostics Clinical Laboratories, Inc.
  • Charles River Laboratories

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Datasheet

10 % Off

USD

3,299

2,969

Single User License

10 % Off

USD

5,499

4,949

Five User License

15 % Off

USD

6,999

5,949

Corporate License

15 % Off

USD

8,199

6,969

Datasheet

USD 3,299

USD 2,969

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

USD 5,499

USD 4,949

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

USD 6,999

USD 5,949

tax inclusive*

  • All Selected Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

USD 8,199

USD 6,969

tax inclusive*

  • All Selected Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124